- Home
- AMSF vs PAHC Comparison
AMSF vs PAHC Comparison
Compare AMSF & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMSF
- PAHC
- Stock Information
- Founded
- AMSF 1985
- PAHC 1946
- Country
- AMSF United States
- PAHC United States
- Employees
- AMSF N/A
- PAHC N/A
- Industry
- AMSF Accident &Health Insurance
- PAHC Biotechnology: Pharmaceutical Preparations
- Sector
- AMSF Finance
- PAHC Health Care
- Exchange
- AMSF Nasdaq
- PAHC Nasdaq
- Market Cap
- AMSF 987.4M
- PAHC 902.8M
- IPO Year
- AMSF 2005
- PAHC 2014
- Fundamental
- Price
- AMSF $49.47
- PAHC $22.50
- Analyst Decision
- AMSF Buy
- PAHC Sell
- Analyst Count
- AMSF 2
- PAHC 4
- Target Price
- AMSF $59.50
- PAHC $21.00
- AVG Volume (30 Days)
- AMSF 62.3K
- PAHC 274.9K
- Earning Date
- AMSF 02-26-2025
- PAHC 02-05-2025
- Dividend Yield
- AMSF 9.06%
- PAHC 2.13%
- EPS Growth
- AMSF N/A
- PAHC 30.53
- EPS
- AMSF 3.21
- PAHC 0.48
- Revenue
- AMSF $315,182,000.00
- PAHC $1,106,080,000.00
- Revenue This Year
- AMSF N/A
- PAHC $28.33
- Revenue Next Year
- AMSF $0.88
- PAHC $10.57
- P/E Ratio
- AMSF $15.41
- PAHC $47.18
- Revenue Growth
- AMSF 2.81
- PAHC 12.63
- 52 Week Low
- AMSF $41.97
- PAHC $11.99
- 52 Week High
- AMSF $60.24
- PAHC $26.55
- Technical
- Relative Strength Index (RSI)
- AMSF 41.28
- PAHC 45.46
- Support Level
- AMSF $48.88
- PAHC $24.33
- Resistance Level
- AMSF $50.25
- PAHC $26.55
- Average True Range (ATR)
- AMSF 0.74
- PAHC 1.29
- MACD
- AMSF 0.02
- PAHC -0.15
- Stochastic Oscillator
- AMSF 27.44
- PAHC 26.43
About AMSF AMERISAFE Inc.
AMERISAFE Inc is a specialty provider of workers' compensation insurance to employers engaged in hazardous industries, mainly construction, trucking, manufacturing, oil and gas, and agriculture. The company generates a majority of its revenue in the form of premiums.
About PAHC Phibro Animal Health Corporation
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.